Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
Recruiting · NCT02638389 · Registry updated 2023-02-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, vascular malformation | Recruiting | Phase 3 | 2023-02-24 | NCT02638389 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 66 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU Caen | Caen | France | 1 |
| Cliniques Universitaires Saint-Luc, Université Catholique de Louvain Bruxelles | Brussels | Belgium | 1 |
| Universitätsklinikum Freiburg | Freiburg im Breisgau | Germany | 34 |